102 related articles for article (PubMed ID: 4334181)
21. Menopause management. Estrogen update.
Harv Womens Health Watch; 1999 Jun; 6(10):6. PubMed ID: 10233808
[No Abstract] [Full Text] [Related]
22. Difrarel 100 in the treatment of retinal vascular disorders and high myopia.
Barradah MA; Shoukry I; Hegazy M
Bull Ophthalmol Soc Egypt; 1967; 60(64):251-2. PubMed ID: 5602916
[No Abstract] [Full Text] [Related]
23. [Recent progress in the therapy of vascular diseases].
Ayres F; Faria FC
Arq Bras Oftalmol; 1967; 30(6):325-52. PubMed ID: 4883838
[No Abstract] [Full Text] [Related]
24. The pharmacokinetics and efficacy of different estrogens are not equivalent.
Ansbacher R
Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
[TBL] [Abstract][Full Text] [Related]
25. The use of premarin, conjugated estrogens-equine to control. Functional uterine bleeding and the urinary estrogen metabolism after administration.
Hamada H
Bull Osaka Med Sch; 1971 Oct; 17(2):130-42. PubMed ID: 4347399
[No Abstract] [Full Text] [Related]
26. Sex, drugs, false dawns, and magic bullets.
Eynon CA
Crit Care Med; 2010 Oct; 38(10):2078-9. PubMed ID: 20856002
[No Abstract] [Full Text] [Related]
27. Conjugated estrogens (Premarin) vaginal cream.
Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
[TBL] [Abstract][Full Text] [Related]
28. [Soluble conjugated estrogens in the prevention of hemorrhages in eye surgery].
Campinchi R; Riquet J; Bertrand C
Bull Soc Ophtalmol Fr; 1971 Mar; 71(3):335-6. PubMed ID: 4333300
[No Abstract] [Full Text] [Related]
29. [Long-term therapy of vascular permeability disorders using anthocyanosides].
Neumann L
Munch Med Wochenschr; 1973 May; 115(20):952-4. PubMed ID: 4740456
[No Abstract] [Full Text] [Related]
30. Physiological and psychological evaluation of the estrogen deprived patient.
Bolding OT; Willcutt HC
J Med Assoc State Ala; 1969 Nov; 39(5):459-63. PubMed ID: 4390875
[No Abstract] [Full Text] [Related]
31. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
[No Abstract] [Full Text] [Related]
32. [On the use of Presomen in the therapy of urogenital hemorrhages].
Rosdy E; Szabó V; Magasi P
Z Urol Nephrol; 1968 Sep; 61(9):597-601. PubMed ID: 4307119
[No Abstract] [Full Text] [Related]
33. Diabetic retinopathy and salicylates.
Carroll WW; Geeraets WJ
Ann Ophthalmol; 1972 Dec; 4(12):1019-45. PubMed ID: 4640731
[No Abstract] [Full Text] [Related]
34. [A clinical use of trans amino methyl cyclohexane carboxylic acid in cases of diabetic retinopathy].
Manabe R; Hoshino T
Nihon Ganka Kiyo; 1966 Apr; 17(4):466-9. PubMed ID: 4225315
[No Abstract] [Full Text] [Related]
35. Treatment of diabetic retinopathy with Retabolil.
Sziklai A
Ther Hung; 1968; 16(2):64-7. PubMed ID: 5666415
[No Abstract] [Full Text] [Related]
36. [Internal medicine and ophthalmology, with reference to retinal hemorrhage].
Murakami M; Kuroda M; Murakoshi Y; Hoshiba I
Saishin Igaku; 1966 Aug; 21(8):1742-8. PubMed ID: 5975035
[No Abstract] [Full Text] [Related]
37. [Action of synthetic derivatives of Congo red. Angiographic study].
Zenatti C
Ann Ocul (Paris); 1971 Mar; 204(3):257-70. PubMed ID: 5089202
[No Abstract] [Full Text] [Related]
38. Estrogen-progestin combinations for postmenopausal use.
Med Lett Drugs Ther; 1995 Jun; 37(950):53-4. PubMed ID: 7760770
[No Abstract] [Full Text] [Related]
39. Mammographic change in hysterectomized women on 0.625 mg/day of conjugated equine estrogen.
Panpanit A; Muttarak M; Pongsatha S; Chaovisitsaree S; Piyamongkol W; Truengthawatchai S; Morakot N; Sribanditmongkol N; Noi-um S; Churith K; Chuntaranikul M
J Med Assoc Thai; 2004 Feb; 87(2):126-30. PubMed ID: 15061294
[TBL] [Abstract][Full Text] [Related]
40. [Calcium dobesilate in diabetic retinopathy].
Wirtel J
Rev Med Liege; 1974 Sep; 29(17):513-5. PubMed ID: 4428113
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
